Aditi Dutt

Array ( [id] => 5397762 [patent_doc_number] => 20090317825 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-24 [patent_title] => 'ASSAY FOR PARKINSON\'S DISEASE THERAPEUTICS AND ENZYMATICALLY ACTIVE PARKIN PREPARATIONS USEFUL THEREIN' [patent_app_type] => utility [patent_app_number] => 12/096890 [patent_app_country] => US [patent_app_date] => 2006-12-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 11905 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0317/20090317825.pdf [firstpage_image] =>[orig_patent_app_number] => 12096890 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5259047 [patent_doc_number] => 20070212679 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-09-13 [patent_title] => 'Assay for parkinson\'s disease therapeutics and enzymatically active parkin preparations useful therein' [patent_app_type] => utility [patent_app_number] => 11/638242 [patent_app_country] => US [patent_app_date] => 2006-12-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 11888 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0212/20070212679.pdf [firstpage_image] =>[orig_patent_app_number] => 11638242 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9401174 [patent_doc_number] => 08691224 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-04-08 [patent_title] => 'Anti-Aβ globulomer 5F7 antibodies' [patent_app_type] => utility [patent_app_number] => 11/574876 [patent_app_country] => US [patent_app_date] => 2006-11-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 11 [patent_no_of_words] => 45844 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11574876 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5112460 [patent_doc_number] => 20070196375 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-08-23 [patent_title] => 'Methods to facilitate transmission of large molecules across the blood-brain, blood-eye, and blood-nerve barriers' [patent_app_type] => utility [patent_app_number] => 11/601799 [patent_app_country] => US [patent_app_date] => 2006-11-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24760 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0196/20070196375.pdf [firstpage_image] =>[orig_patent_app_number] => 11601799 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5194364 [patent_doc_number] => 20070082848 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-04-12 [patent_title] => 'VEGF-C or VEGF-D materials and methods for treatment of neuropathologies' [patent_app_type] => utility [patent_app_number] => 11/600479 [patent_app_country] => US [patent_app_date] => 2006-11-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 41262 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0082/20070082848.pdf [firstpage_image] =>[orig_patent_app_number] => 11600479 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5091667 [patent_doc_number] => 20070231306 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-10-04 [patent_title] => 'Isolated myeloid-like cell populations and methods of treatment therewith' [patent_app_type] => utility [patent_app_number] => 11/600895 [patent_app_country] => US [patent_app_date] => 2006-11-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 64 [patent_figures_cnt] => 64 [patent_no_of_words] => 26961 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0231/20070231306.pdf [firstpage_image] =>[orig_patent_app_number] => 11600895 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5580500 [patent_doc_number] => 20090175846 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-09 [patent_title] => 'Oligodendrocyte-Myelin Glycoprotein Compositions and Methods of Use Thereof' [patent_app_type] => utility [patent_app_number] => 12/091564 [patent_app_country] => US [patent_app_date] => 2006-10-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 45526 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 23 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0175/20090175846.pdf [firstpage_image] =>[orig_patent_app_number] => 12091564 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5374158 [patent_doc_number] => 20090311719 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-17 [patent_title] => 'IN VITRO METHOD FOR DIAGNOSING NEURODEGENERATIVE DISEASES' [patent_app_type] => utility [patent_app_number] => 12/091261 [patent_app_country] => US [patent_app_date] => 2006-10-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 4906 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0311/20090311719.pdf [firstpage_image] =>[orig_patent_app_number] => 12091261 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 130777 [patent_doc_number] => 07700099 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-04-20 [patent_title] => 'Non-immunostimulatory antibody and compositions containing the same' [patent_app_type] => utility [patent_app_number] => 11/581931 [patent_app_country] => US [patent_app_date] => 2006-10-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 5 [patent_no_of_words] => 6093 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 75 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/700/07700099.pdf [firstpage_image] =>[orig_patent_app_number] => 11581931 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4989324 [patent_doc_number] => 20070155665 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-07-05 [patent_title] => 'Neuregulins for prevention and treatment of damage from acute assault on vascular and neuronal tissue and as regulators of neuronal stem cell migration' [patent_app_type] => utility [patent_app_number] => 11/514352 [patent_app_country] => US [patent_app_date] => 2006-09-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7571 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0155/20070155665.pdf [firstpage_image] =>[orig_patent_app_number] => 11514352 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5141317 [patent_doc_number] => 20070003533 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-01-04 [patent_title] => 'Inhibition of the beta3 subunit of L-type Ca2+ channels' [patent_app_type] => utility [patent_app_number] => 11/510105 [patent_app_country] => US [patent_app_date] => 2006-08-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 12104 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0003/20070003533.pdf [firstpage_image] =>[orig_patent_app_number] => 11510105 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5000323 [patent_doc_number] => 20070042957 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-02-22 [patent_title] => 'TYPE V PHOSPHODIESTERASE INHIBITORS AND NATRIURETIC POLYPEPTIDES' [patent_app_type] => utility [patent_app_number] => 11/465380 [patent_app_country] => US [patent_app_date] => 2006-08-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 7808 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0042/20070042957.pdf [firstpage_image] =>[orig_patent_app_number] => 11465380 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5148169 [patent_doc_number] => 20070048225 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-03-01 [patent_title] => 'NK3 receptor in vivo assay' [patent_app_type] => utility [patent_app_number] => 11/504241 [patent_app_country] => US [patent_app_date] => 2006-08-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 1839 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0048/20070048225.pdf [firstpage_image] =>[orig_patent_app_number] => 11504241 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10143312 [patent_doc_number] => 09176119 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-11-03 [patent_title] => 'Method for quantifying a cholinergic neurotoxin in a sample' [patent_app_type] => utility [patent_app_number] => 12/065523 [patent_app_country] => US [patent_app_date] => 2006-08-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 2851 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 86 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12065523 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5236468 [patent_doc_number] => 20070128625 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-06-07 [patent_title] => 'Drug-resistant mutants of hepatitis C virus' [patent_app_type] => utility [patent_app_number] => 11/491756 [patent_app_country] => US [patent_app_date] => 2006-07-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 4980 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0128/20070128625.pdf [firstpage_image] =>[orig_patent_app_number] => 11491756 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4683380 [patent_doc_number] => 20080249606 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-09 [patent_title] => 'Methods for Determining the Effect of a Treatment on the Cross-Beta Structure Content of a Protein; Selection of Treatments and Uses Thereof' [patent_app_type] => utility [patent_app_number] => 11/995508 [patent_app_country] => US [patent_app_date] => 2006-07-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 17512 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0249/20080249606.pdf [firstpage_image] =>[orig_patent_app_number] => 11995508 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5075219 [patent_doc_number] => 20070015194 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-01-18 [patent_title] => 'Methods and kits for diagnosing and treating mental retardation' [patent_app_type] => utility [patent_app_number] => 11/484719 [patent_app_country] => US [patent_app_date] => 2006-07-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 33658 [patent_no_of_claims] => 47 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0015/20070015194.pdf [firstpage_image] =>[orig_patent_app_number] => 11484719 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9311805 [patent_doc_number] => 08653023 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2014-02-18 [patent_title] => 'Dual beneficial effect of dopamine enhancing and neuroprotective actions of PKC delta inhibitors for treatment of Parkinson\'s disease' [patent_app_type] => utility [patent_app_number] => 11/479173 [patent_app_country] => US [patent_app_date] => 2006-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 25462 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 69 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11479173 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 588976 [patent_doc_number] => 07439328 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-10-21 [patent_title] => 'Tctex-1-related polypeptides' [patent_app_type] => utility [patent_app_number] => 11/428122 [patent_app_country] => US [patent_app_date] => 2006-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 85 [patent_no_of_words] => 23254 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/439/07439328.pdf [firstpage_image] =>[orig_patent_app_number] => 11428122 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5141765 [patent_doc_number] => 20070003981 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-01-04 [patent_title] => 'Methods and kits for the diagnosis of acute coronary syndrome' [patent_app_type] => utility [patent_app_number] => 11/475249 [patent_app_country] => US [patent_app_date] => 2006-06-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 11482 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0003/20070003981.pdf [firstpage_image] =>[orig_patent_app_number] => 11475249 [rel_patent_id] =>[rel_patent_doc_number] =>)